BC
WST icon

Brinker Capital’s West Pharmaceutical WST Stock Holding History

Brinker Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.73M Sell
16,429
-3,199
-16% -$629K 0.12% 180
2020
Q1 		$2.99M Sell
19,628
-2,329
-11% -$358K 0.12% 177
2019
Q4 		$3.3M Buy
21,957
+1,005
+5% +$146K 0.1% 196
2019
Q3 		$2.97M Sell
20,952
-1,701
-8% -$234K 0.1% 198
2019
Q2 		$2.83M Buy
22,653
+1
+0% +$118 0.1% 185
2019
Q1 		$2.5M Buy
22,652
+1,331
+6% +$138K 0.09% 205
2018
Q4 		$2.09M Buy
21,321
+1,653
+8% +$179K 0.09% 209
2018
Q3 		$2.43M Sell
19,668
-2,867
-13% -$322K 0.09% 231
2018
Q2 		$2.24M Buy
22,535
+224
+1% +$20.6K 0.09% 244
2018
Q1 		$1.97M Buy
22,311
+2,005
+10% +$188K 0.08% 263
2017
Q4 		$2M Buy
20,306
+363
+2% +$35.6K 0.08% 242
2017
Q3 		$1.92M Buy
19,943
+1,872
+10% +$169K 0.08% 238
2017
Q2 		$1.71M Sell
18,071
-3,479
-16% -$320K 0.08% 252
2017
Q1 		$1.76M Buy
21,550
+11,417
+113% +$955K 0.08% 238
2016
Q4 		$860K Buy
+10,133
New +$797K 0.05% 328

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Brinker Capital's WST Position: Q2 2020 in Review

Brinker Capital reduced its West Pharmaceutical (WST) stake by 16% in Q2 2020, selling an estimated $629K and leaving 16,429 shares worth $3.73M. The position accounts for 0.12% of the portfolio, ranked #180.

Brinker Capital first reported a position in WST in Q4 2016 and has held it in 15 quarters since. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Brinker Capital held 16,429 shares of West Pharmaceutical worth $3.73M as of Q2 2020.
  • Brinker Capital sold 3,199 West Pharmaceutical shares in Q2 2020, an estimated $629K.
  • West Pharmaceutical made up 0.12% of Brinker Capital's portfolio in Q2 2020, its #180 holding.
  • Brinker Capital first reported a position in West Pharmaceutical in Q4 2016 and has held it in 15 quarters since.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.